Heights is a company.
Heights has raised $2.0M across 1 funding round.
Key people at Heights.
Heights has raised $2.0M in total across 1 funding round.
Heights has raised $2.0M in total across 1 funding round.
Heights's investors include ACF Investors, Rianta Capital, TrueSight Ventures, Biz Stone, Paul Forster.
Key people at Heights.
Heights Capital Management is a global investment firm affiliated with Susquehanna, one of the world's largest privately-held financial services firms, focused on deploying Susquehanna's proprietary capital into high-growth public companies across biotech, healthcare, technology, financial services, media, energy services, and natural resources.[1] Its investment philosophy emphasizes long-term support for strong management teams without exerting control, leveraging flexibility from no fund redemptions, fundraising pressure, or LP obligations to back growth post-IPO or in listed equities worldwide.[1] With offices in San Francisco, Philadelphia, Dublin, London, and Hong Kong, Heights has executed hundreds of equity and equity-linked investments, significantly impacting the startup and growth ecosystem by providing patient capital to leading firms in high-potential sectors.[1]
This approach differentiates Heights from traditional funds, enabling innovative support for investees while sharing in their upside, particularly in Asia where Susquehanna has invested over $3.5 billion in more than 350 companies since 2005.[1]
Heights Capital traces its roots to 1996, when it was established as the direct investment arm of Susquehanna to manage internal capital deployments into listed companies globally.[1] Susquehanna itself began operations in Tokyo in 1991, expanding across Asia with a strong presence in options market-making, ETFs, and commodities trading, which laid the groundwork for Heights' regional focus.[1] The firm evolved from U.S.-centric investments to a global platform, opening its Asia office in 2017 to target post-IPO growth companies in China, Japan, India, and Southeast Asia, building on Susquehanna's established network employing over 400 people regionally.[1]
Key evolution points include leveraging Susquehanna's trading expertise for equity-linked deals and shifting emphasis toward high-growth sectors amid rising public market opportunities in biotech and tech.[1]
Heights Capital rides the wave of post-IPO growth investing in a landscape where high-growth tech, biotech, and healthcare firms increasingly stay public longer amid volatile IPO markets and abundant late-stage private capital.[1] Timing is ideal as sectors like biotech and clean energy face regulatory tailwinds and innovation booms, with Heights' flexibility countering short-termism in public markets.[1] Market forces favoring it include Susquehanna's trading dominance for deal sourcing and Asia's rising tech hubs (China, India), where post-IPO liquidity needs align with Heights' expertise.[1] It influences the ecosystem by bridging private-to-public transitions, supporting scaling without dilution pressure, and exemplifying how proprietary trading capital sustains innovation in fragmented global markets.[1]
Heights Capital is poised to expand in AI-driven biotech, renewable energy, and Asia tech, capitalizing on Susquehanna's edge in volatile markets amid geopolitical shifts and rate normalization.[1] Trends like extended growth phases for unicorns and equity-linked financing will amplify its role, potentially doubling Asia deployments as regional IPOs rebound.[1] Its influence may evolve toward deeper operating partnerships, solidifying as a quiet force behind tomorrow's market leaders—echoing its origins in patient, high-conviction bets on global growth engines.[1]
Heights has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in January 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2021 | $2.0M Seed | ACF Investors, Rianta Capital, TrueSight Ventures, Biz Stone, Paul Forster |
